期刊文献+

新辅助治疗在局部晚期乳腺癌中的应用 被引量:13

Neo-adjuvant Therapy in the Treatment of Locally Advanced Breast Cancer
下载PDF
导出
摘要 探讨新辅助治疗在局部晚期乳腺癌治疗中的应用。方法:回顾性分析36例局部晚期乳腺癌患者进行新辅助治疗的临床资料。结果:36例患者中29例(80%)经新辅助治疗后病情缓解,可以手术。其中27例由化疗获得,2例由内分泌治疗获得。结论:大多数局部晚期乳腺癌患者可以在1~2个疗程的新辅助治疗后病情缓解,便于手术治疗,从而改善预后。 Objective:To evaluate the effect of neoadjuvant therapy in the treatment of lo-cally advanced breast cancer.Methods:36patients with locally advanced breast treated by neoadjuvant therapy were reviewed retrospectively.Results:After neoadjuvant therapy,29(80%)patients got partial response and some of the primary inoperable lesions became respectable,27cases by chemotherapy,2cases by endocrine therapy.Conclusions:It can make operation more easily for the locally advanced breast cancer patients after1to2courses of neoadjuvant therapy and get a better prognosis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第4期283-285,共3页 Chinese Journal of Clinical Oncology
关键词 局部 晚期 乳腺癌 新辅助化疗 内分泌治疗 Breast cancer Neo-adjuvant chemotherapy Endocrine therapy
  • 相关文献

参考文献17

  • 1[1]Inaji H, Komoike Y, Motomura K, et al. Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer[J]. Breast Cancer, 2002, 9(1):20~25
  • 2[2]Newman LA, Buzdar AU, Singletary SE, et al. A prospective trial of preoperative chemotherapy in resectable breast cancer:predictors of breast-conservation therapy feasibility [J]. Ann Surg Oncol, 2002, 9(3):217~219
  • 3[3]Kuerer HM, Singletary SE, Brzdar AU, et al. Surgical conservation planning after neoadjuvant chemotherapy for stage Ⅱ and operable stage Ⅲ breast carcinoma[J]. Am J Surg, 2001,182(6):601~608
  • 4[4]Baslaim MM, A1 Malik OA, Al Sobhi SS, et al. Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy[J]. Am J Surg, 2002, 184 (4): 299~301
  • 5[5]Gradishar WJ. Primary (neoadjuvant) chemotherapy with docetaxel in breast cancer[J]. Clin Breast Cancer, 2001, 2(Suppl 1):S31~35
  • 6[6]Smith IC, Heys SD, Hutcheon AW, et al, Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel[J]. J Clin Oncol 2002, 20 (6): 1456~1466
  • 7[7]De Matteis A, Nuzzo F, D'Aiuto G. Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: a single-center, phase Ⅱ study[J]. Cancer, 2002,94(4):895~901
  • 8[8]Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage Ⅲ primary breast cancer with primary chemotherapy,surgery, and radiation therapy[J]. Cancer, 1988, 62(12):2507~2516
  • 9[9]Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18[J]. J Clin Oncol, 1997, 15:2483~2495
  • 10[10]Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer[J]. J Clin Oncol, 1998, 16:2672~2685

同被引文献86

引证文献13

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部